HER2-POSITIVE

Clinical trials for HER2-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HER2-POSITIVE trials appear

Sign up with your email to follow new studies for HER2-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug aims to wipe out early breast cancer before surgery

Disease control Recruiting now

This study tests a drug called zanidatamab in 20 people with early-stage HER2-positive breast cancer. The goal is to see if the drug can make the cancer disappear before surgery. Participants will receive the drug and then have surgery to check if the cancer is gone.

Matched conditions: HER2-POSITIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

HER2-POSITIVE

Get alerted when new HER2-POSITIVE trials appear

New drug aims to wipe out early breast cancer before surgery